Time to Double Down: Dual Immunotherapy as the Best Bet for Treatment of Microsatellite Instability-High Metastatic Colorectal Cancer

Clinical Colorectal Cancer · Published 2026-07-01 · DOI 10.1016/j.clcc.2026.07.003

Authors (2)

Mir Lim, Van K Morris

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lim, M., Morris, V. (2026). Time to Double Down: Dual Immunotherapy as the Best Bet for Treatment of Microsatellite Instability-High Metastatic Colorectal Cancer. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2026.07.003

Related articles

• MRI Monitoring of Locally Advanced Rectal Cancer in Watch and Wait Patients · Clinical Colorectal Cancer · 2025 · Same journal
• Number of Lymph Nodes Examined as a Prognosis Factor in Patients With Stage II or III Colon Cancer · Clinical Colorectal Cancer · 2025 · Same journal
• Dietary Diabetes Risk Reduction Score (DDRRS) and the Risk of Colorectal Cancer and Adenoma: A Case-Control Study · Clinical Colorectal Cancer · 2025 · Same journal
• Does Extramural Vascular Invasion Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer? · Clinical Colorectal Cancer · 2025 · Same journal
• Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study) · Clinical Colorectal Cancer · 2025 · Same journal
• Age as a Modifier of the Effects of Sarcopenia on Survival Among Colon Cancer Patients Receiving Chemotherapy · Clinical Colorectal Cancer · 2025 · Same journal
• The Effect of Total Neoadjuvant Treatment on Pathological Response and Survival in Locally Advanced Rectal Cancer: A Single Center Experience · Clinical Colorectal Cancer · 2025 · Same journal
• Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer · Clinical Colorectal Cancer · 2026 · Same journal
• Misdiagnosed: A Sigmoid Perforation Secondary to Visceral Kaposi Sarcoma · Clinical Colorectal Cancer · 2025 · Same journal
• Randomized phase III Study of Adding Paclitaxel to Chemoradiotherapy With Capecitabine and Mitomycin C in Squamous Cell Anal Carcinoma · Clinical Colorectal Cancer · 2026 · Same journal